(1) On November 30, 2010, the Reporting Person acquired 250,000 shares of Series D Preferred Stock of the Issuer. The Series D Preferred Stock are non-registered securities, non-convertible and each share provides the Reporting Person super-voting rights at any meeting of the stockholders of the Issuer and such shares of Series D Preferred Stock will vote together with the common stockholders of the Issuer, provided for the election or removal of directors the shares of Series D Preferred Stock will be voted in the same percentage as all voting shares of common stock voted for each director, in the amount of 400 votes per Series D Preferred Stock equaling an aggregate of 100,000,000 votes. If calculated with 7, 9, 11 and 13 above, sole voting power would equal 174,848.050 votes, aggregate amount beneficially owned by each reporting person would equal 174,848,050 votes and the percent of class represented by the amount in Row 11 would be 64.1%.

(2) The Reporting Person may be deemed to indirectly beneficially own 49,644,716 shares of common stock held as sole trustee of the Cornelis F. Wit Revocable Living Trust Dated October 15, 2009 as Amended and Restated on June 11, 2015.

EXPLANATORY NOTE

This Amendment No. 7 to the Original Schedule 13D, as defined herein, (“Amendment No. 7”) amends the Schedule 13D originally filed by the Reporting Person with the Commission on December 29, 2008 (the “Original Schedule 13D”), Amendment No. 1 to the Original Schedule 13D originally filed by the Reporting Person with the Commission on March 2, 2010 (“Amendment No. 1”), Amendment No. 2 to the Original Schedule 13D originally filed by the Reporting Person with the Commission on February 23, 2012 (“Amendment No. 2”), Amendment No. 3 to the Original Schedule 13D originally filed by the Reporting Person with the Commission on March 22, 2013 (“Amendment No. 3”), Amendment No. 4 to the Original Schedule 13D originally filed by the Reporting Person with the Commission on May 23, 2014 (“Amendment No. 4”), Amendment No. 5 to the Original Schedule 13D originally filed by the Reporting Person with the Commission on November 20, 2015 (“Amendment No. 5”) and Amendment No. 6 to the Original Schedule 13D originally filed by the Reporting Person with the Commission on November 25, 2015 (“Amendment No. 6”). The Original Schedule 13D, Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5 and Amendment No. 6 are collectively referred to as the “Schedule 13D.”

All terms used but not defined in this Amendment No. 7 are as defined in the Schedule 13D. The summary descriptions (if any) contained herein of certain agreements and documents are qualified in their entirety by reference to the complete text of such agreements and documents filed as Exhibits hereto or incorporated herein by reference.

This Amendment No. 7 is being filed to (i) update beneficial ownership information of the Reporting Person as a result of (I) a contribution of an aggregate of 49,724,716 shares of common stock that had previously been acquired and held directly by the Reporting Person to the Cornelis F. Wit Revocable Living Trust Dated October 15, 2009 as Amended and Restated on June 11, 2015, which trust is a revocable trust established by the Reporting Person as grantor with respect to which the Reporting Person is the sole trustee, and the Reporting Person, his spouse and children are beneficiaries (the “Trust”), and, as a result, the Reporting Person may be deemed to have retained beneficial ownership of such shares, and (II) transactions occurring since the date of Amendment No. 6, and (ii) to report a decrease in the Reporting Person’s percentage ownership of the common stock resulting from the increase in the number of outstanding shares of common stock of the Issuer.

  Item 3 of the Schedule 13D is amended and supplemented as follows:

Since the most recent filing of an amendment to the Original Schedule 13D on November 25, 2015, the Reporting Person effected the following transactions:

(i) on December 17, 2015, the Reporting Person entered into a Stock Purchase Agreement pursuant to which, in a privately negotiated transaction, the Reporting Person sold warrants to purchase 2,000,000 shares of common stock of the Issuer at an exercise price of $0.25 per share with an expiration date of January 1, 2019 to Randall G. Smith, Chairman of the Board and Chief Technology Officer of the Issuer, in exchange for a cash amount of $60,000,

(ii) January 21, 2016, the Reporting Person contributed 49,644,716 shares of common stock that had previously been acquired and held directly by the Reporting Person to the Trust,

(iii) on February 29, 2016, the Issuer issued the Reporting Person a promissory note in the amount of $450,000 and, in consideration thereof, warrants convertible into 1,800,000 shares of common stock at an exercise price of $0.25 per shares with an expiration date of April 1, 2019,

(iv) on June 30, 2016, the Issuer and the Reporting Person extended the conversion date of an aggregate amount of $5,825,000 Convertible Debentures convertible into an aggregate of 11,650,000 shares of common stock to April 1, 2020, and extended the expiration date of related warrants exercisable into 11,650,000 shares of common stock at an exercise price of $0.50 per share to April 1, 2020,

(v) on August 16, 2016, the Reporting Person purchased, with personal funds, 80,000 shares of common stock in a privately negotiated transaction for $0.15 per share, which 80,000 shares were contributed to the Trust on September 6, 2016, and

(vi) on December 5, 2016, the Reporting Person entered into a Stock Purchase Agreement pursuant to which, in a privately negotiated transaction, the Reporting Person sold warrants to purchase 1,000,000 shares of common stock of the Issuer at an exercise price of $0.25 per share with an expiration date of January 1, 2019 to Abrey K. Light, Executive Vice President of the Issuer, in exchange for a cash amount of $30,000.

Item 5 of the Schedule 13D is amended and supplemented as follows:

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 13, 2017